Anna Protopapas

(Ms. Anna Protopapas)

Currently holds positions in Dicerna Pharmaceuticals Inc and Mersana Therapeutics Inc

Positions
Position Company Period
Independent Director Dicerna Pharmaceuticals Inc Jan. 23, 2019 -
President, Chief Executive Officer, Director Mersana Therapeutics Inc March 1, 2015 -
Independent Director Bioverativ Inc Feb. 1, 2017 - March 8, 2018
Independent Director ARIAD Pharmaceuticals Inc April 28, 2015 - Feb. 16, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2024-01-17 2024-01-16
PS Planned sale
29,399 -19.0%
2.71
79,671 USD
29,399 -19.0% 2.71 79,671 USD
2023-12-20 2023-12-18
US Nuvalent Inc (NUVL)
S Sale
5,000 -100.0%
75.67
378,350 USD
5,000 -100.0% 75.67 378,350 USD
2023-01-18 2023-01-17
S Sale
17,346 -26.3%
5.74
99,566 USD
17,346 -26.3% 5.74 99,566 USD